PPA
SGYP

Parametric Portfolio Associates’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Parametric Portfolio Associates’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,120
Closed -$50K – 4019
2018
Q3 		$50K Sell
29,120
-27,876
-49% -$49.9K ﹤0.01% 3908
2018
Q2 		$99K Buy
56,996
+8,170
+17% +$14.1K ﹤0.01% 3810
2018
Q1 		$89K Sell
48,826
-75,040
-61% -$158K ﹤0.01% 3868
2017
Q4 		$276K Sell
123,866
-231,177
-65% -$575K ﹤0.01% 3608
2017
Q3 		$1.03M Buy
355,043
+54,262
+18% +$185K ﹤0.01% 3027
2017
Q2 		$1.34M Buy
300,781
+51,505
+21% +$212K ﹤0.01% 2805
2017
Q1 		$1.16M Buy
249,276
+150,130
+151% +$871K ﹤0.01% 2788
2016
Q4 		$604K Buy
99,146
+23,800
+32% +$124K ﹤0.01% 3094
2016
Q3 		$415K Buy
75,346
+8,778
+13% +$41.1K ﹤0.01% 3259
2016
Q2 		$253K Buy
66,568
+37,750
+131% +$128K ﹤0.01% 3523
2016
Q1 		$80K Sell
28,818
-19,717
-41% -$71.4K ﹤0.01% 3887
2015
Q4 		$275K Sell
48,535
-2,050
-4% -$12.5K ﹤0.01% 3598
2015
Q3 		$268K Sell
50,585
-24,405
-33% -$189K ﹤0.01% 3010
2015
Q2 		$622K Buy
74,990
+31,048
+71% +$150K ﹤0.01% 3131
2015
Q1 		$203K Buy
43,942
+30,559
+228% +$99.4K ﹤0.01% 3744
2014
Q4 		$41K Buy
+13,383
New +$39.6K ﹤0.01% 3955
2014
Q2 		– Sell
-14,298
Closed -$76K – 3833
2014
Q1 		$76K Buy
14,298
+1,994
+16% +$11.2K ﹤0.01% 3757
2013
Q4 		$68K Sell
12,304
-61,939
-83% -$267K ﹤0.01% 3758
2013
Q3 		$335K Buy
74,243
+62,550
+535% +$280K ﹤0.01% 3330
2013
Q2 		$50K Buy
+11,693
New +$58.7K ﹤0.01% 3663

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Parametric Portfolio Associates's SGYP Position: Q4 2018 in Review

Parametric Portfolio Associates sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 29,120 shares — an estimated $50K sold.

Parametric Portfolio Associates first reported a position in SGYP in Q2 2013 and held it in 20 quarters. The position peaked at $1.34M in Q2 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Parametric Portfolio Associates reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Parametric Portfolio Associates sold 29,120 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $50K.
  • Parametric Portfolio Associates first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 20 quarters.
  • Parametric Portfolio Associates's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.34M in Q2 2017.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Parametric Portfolio Associates's 13F filing for Q4 2018, filed 14 Feb 2019.